000			02161 a2200613 4500
005			20250517002615.0
264		0	_c20160211
008			201602s 0 0 eng d
022			_a1933-7205
024	7		_a10.1177/1933719114557893 _2doi
040			_aNLM _beng _cNLM
100	1		_aChiang, Ying-Cheng
245	0	0	_aEstablishment of a New Ovarian Cancer Cell Line CA5171. _h[electronic resource]
260			_bReproductive sciences (Thousand Oaks, Calif.) _cJun 2015
300			_a725-34 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aCarcinoma, Ovarian Epithelial
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement
650	0	4	_aCell Proliferation
650	0	4	_aCell Shape
650	0	4	_aCisplatin _xpharmacology
650	0	4	_aClass I Phosphatidylinositol 3-Kinases
650	0	4	_aDNA Copy Number Variations
650	0	4	_aDoxorubicin _xpharmacology
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aEpithelial-Mesenchymal Transition
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aNeoplasms, Glandular and Epithelial _xdrug therapy
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPTEN Phosphohydrolase _xgenetics
650	0	4	_aPaclitaxel _xpharmacology
650	0	4	_aPhenotype
650	0	4	_aPhosphatidylinositol 3-Kinases _xgenetics
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aTumor Suppressor Protein p53 _xgenetics
700	1		_aCheng, Wen-Fang
700	1		_aChang, Ming-Cheng
700	1		_aLu, Tzu-Pin
700	1		_aKuo, Kuan-Ting
700	1		_aLin, Hsiu-Ping
700	1		_aHsieh, Chang-Yao
700	1		_aChen, Chi-An
773	0		_tReproductive sciences (Thousand Oaks, Calif.) _gvol. 22 _gno. 6 _gp. 725-34
856	4	0	_uhttps://doi.org/10.1177/1933719114557893 _zAvailable from publisher's website
999			_c24352286 _d24352286